GlassScriptPhysician profile
Meaghan I Descher
NPI 1538322912
$4,201.87
in general payments reported to CMS, 2019-2025
28 companies · $676 in 2025
The $676 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $915 · 2022: $627 · 2023: $768 · 2024: $1,216 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,660.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,097.98 | 2021-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $684.44 | 2021-2024 | Relistor |
| Boston Scientific Corporation | $372.46 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $325.64 | 2021-2025 | Octrode, Eterna, Proclaim |
| Nevro Corp. | $180.88 | 2021-2024 | Senza |
| Biodelivery Sciences International, INC. | $176.55 | 2021 | |
| Biotronik Nro, INC. | $148.25 | 2024 | Prospera |
| Abbvie INC. | $129.13 | 2023-2025 | |
| Vertos Medical, INC. | $128.82 | 2024 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $104.75 | 2024-2025 | |
| Medtronic, INC. | $90.56 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Valinor Pharma, LLC | $90.19 | 2023-2025 | Movantik |
| Pfizer INC. | $89.51 | 2023-2025 | |
| Scilex Pharmaceuticals INC. | $81.71 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $63.81 | 2024-2025 | Wainua |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $59.10 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $49.14 | 2022 | |
| Nalu Medical, INC. | $47.84 | 2025 | Nalu Neurostimulation System |
| Ibsa Pharma INC. | $46.95 | 2024 | Tirosint, Licart |
| Averitas Pharma INC. | $45.40 | 2024-2025 | Qutenza |
| Si-Bone, INC. | $38.81 | 2023 | |
| Mml US, INC. | $31.73 | 2025 | Reactiv8 |
| Grt US Holding, INC. | $31.09 | 2021 | |
| Electronic Waveform Lab, INC. | $22.24 | 2024 | |
| Lilly USA, LLC | $19.18 | 2023 | Emgality |
| Redhill Biopharma INC. | $15.47 | 2021 | |
| Painteq LLC | $15.37 | 2021 | |
| Relievant Medsystems, INC. | $14.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meaghan Descher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.